المؤلفون: G. De Mattia, Stefano Porru, M.S. Varalta, G. Salandini, Francesca Moretti, Stefano Tardivo, Silvia Panunzi, G. Lo Cascio, Irene Campagna, G. Turrina, Gianluca Spiteri, Albino Poli, Roberto Benoni, Chiara Bovo

المصدر: Public Health

مصطلحات موضوعية: Adult, medicine.medical_specialty, Multivariate analysis, Health Personnel, COVID-19, Health surveillance, Healthcare workers, Recovery time, Swab test, Asymptomatic, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Pandemic, Health care, medicine, Humans, 030212 general & internal medicine, Pandemics, Survival analysis, Original Research, Retrospective Studies, business.industry, SARS-CoV-2, 030503 health policy & services, Public Health, Environmental and Occupational Health, Retrospective cohort study, General Medicine, Confidence interval, Personnel, Hospital, Italy, Emergency medicine, Cohort, medicine.symptom, 0305 other medical science, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b834d203d44cb3f5970c7b9e765ec7e7
https://pubmed.ncbi.nlm.nih.gov/34144335

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Cetto GL; Division of Medical Oncology, University of Verona, Italy., Franceschi T, Turrina G, Chiarion-Sileni V, Capelli MC, Bellini A, Paccagnella A, Bassetto MA, Molino AM, de Sandre G

المصدر: Seminars in surgical oncology [Semin Surg Oncol] 1988; Vol. 4 (3), pp. 184-90.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8503713 Publication Model: Print Cited Medium: Print ISSN: 8756-0437 (Print) Linking ISSN: 10982388 NLM ISO Abbreviation: Semin Surg Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Kidney Neoplasms*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Carcinoma, Renal Cell/*secondary , Interferon Type I/*administration & dosage , Interferon-alpha/*administration & dosage , Vinblastine/*administration & dosage, Adult ; Aged ; Carcinoma, Renal Cell/mortality ; Carcinoma, Renal Cell/therapy ; Drug Administration Schedule ; Drug Evaluation ; Female ; Humans ; Interferon alpha-2 ; Interferon-alpha/adverse effects ; Male ; Middle Aged ; Recombinant Proteins ; Vinblastine/adverse effects